Kindly MD, Inc.
Kindly MD, Inc. KDLYW Peers
See (KDLYW) competitors and their performances in Stock Market.
Peer Comparison Table: Medical - Care Facilities Industry
Detailed financial metrics including price, market cap, P/E ratio, and more.
| Symbol | Price | Change % | Market Cap | P/E Ratio | EPS | Dividend Yield |
|---|---|---|---|---|---|---|
| KDLYW | $18.65 | +19.14% | 96.5M | N/A | N/A | N/A |
| HCA | $383.10 | +1.00% | 92.2B | 17.02 | $22.51 | +0.72% |
| FMS | $28.57 | +1.28% | 16.8B | 23.62 | $1.21 | +2.76% |
| THC | $176.00 | +1.36% | 16.3B | 11.30 | $15.58 | N/A |
| SOLV | $75.84 | +0.50% | 13.1B | 34.94 | $2.17 | N/A |
| EHC | $122.63 | +0.35% | 12.4B | 25.22 | $4.86 | +0.54% |
| UHS | $181.15 | +1.72% | 11.7B | 10.18 | $17.81 | +0.44% |
| DVA | $142.45 | +0.55% | 10.8B | 14.13 | $10.08 | N/A |
| OSH | $39.00 | +0.08% | 9.5B | -17.65 | -$2.21 | N/A |
| ENSG | $154.26 | +0.59% | 8.9B | 29.11 | $5.30 | +0.16% |
Stock Comparison
KDLYW vs HCA Comparison
KDLYW plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, KDLYW stands at 96.5M. In comparison, HCA has a market cap of 92.2B. Regarding current trading prices, KDLYW is priced at $18.65, while HCA trades at $383.10.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
KDLYW currently has a P/E ratio of N/A, whereas HCA's P/E ratio is 17.02. In terms of profitability, KDLYW's ROE is -1.46%, compared to HCA's ROE of -2.36%. Regarding short-term risk, KDLYW is more volatile compared to HCA. This indicates potentially higher risk in terms of short-term price fluctuations for KDLYW.
KDLYW vs FMS Comparison
KDLYW plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, KDLYW stands at 96.5M. In comparison, FMS has a market cap of 16.8B. Regarding current trading prices, KDLYW is priced at $18.65, while FMS trades at $28.57.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
KDLYW currently has a P/E ratio of N/A, whereas FMS's P/E ratio is 23.62. In terms of profitability, KDLYW's ROE is -1.46%, compared to FMS's ROE of +0.04%. Regarding short-term risk, KDLYW is more volatile compared to FMS. This indicates potentially higher risk in terms of short-term price fluctuations for KDLYW.
KDLYW vs THC Comparison
KDLYW plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, KDLYW stands at 96.5M. In comparison, THC has a market cap of 16.3B. Regarding current trading prices, KDLYW is priced at $18.65, while THC trades at $176.00.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
KDLYW currently has a P/E ratio of N/A, whereas THC's P/E ratio is 11.30. In terms of profitability, KDLYW's ROE is -1.46%, compared to THC's ROE of +0.37%. Regarding short-term risk, KDLYW is more volatile compared to THC. This indicates potentially higher risk in terms of short-term price fluctuations for KDLYW.
KDLYW vs SOLV Comparison
KDLYW plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, KDLYW stands at 96.5M. In comparison, SOLV has a market cap of 13.1B. Regarding current trading prices, KDLYW is priced at $18.65, while SOLV trades at $75.84.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
KDLYW currently has a P/E ratio of N/A, whereas SOLV's P/E ratio is 34.94. In terms of profitability, KDLYW's ROE is -1.46%, compared to SOLV's ROE of +0.12%. Regarding short-term risk, KDLYW is more volatile compared to SOLV. This indicates potentially higher risk in terms of short-term price fluctuations for KDLYW.
KDLYW vs EHC Comparison
KDLYW plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, KDLYW stands at 96.5M. In comparison, EHC has a market cap of 12.4B. Regarding current trading prices, KDLYW is priced at $18.65, while EHC trades at $122.63.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
KDLYW currently has a P/E ratio of N/A, whereas EHC's P/E ratio is 25.22. In terms of profitability, KDLYW's ROE is -1.46%, compared to EHC's ROE of +0.25%. Regarding short-term risk, KDLYW is more volatile compared to EHC. This indicates potentially higher risk in terms of short-term price fluctuations for KDLYW.
KDLYW vs UHS Comparison
KDLYW plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, KDLYW stands at 96.5M. In comparison, UHS has a market cap of 11.7B. Regarding current trading prices, KDLYW is priced at $18.65, while UHS trades at $181.15.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
KDLYW currently has a P/E ratio of N/A, whereas UHS's P/E ratio is 10.18. In terms of profitability, KDLYW's ROE is -1.46%, compared to UHS's ROE of +0.18%. Regarding short-term risk, KDLYW is more volatile compared to UHS. This indicates potentially higher risk in terms of short-term price fluctuations for KDLYW.
KDLYW vs DVA Comparison
KDLYW plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, KDLYW stands at 96.5M. In comparison, DVA has a market cap of 10.8B. Regarding current trading prices, KDLYW is priced at $18.65, while DVA trades at $142.45.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
KDLYW currently has a P/E ratio of N/A, whereas DVA's P/E ratio is 14.13. In terms of profitability, KDLYW's ROE is -1.46%, compared to DVA's ROE of +3.94%. Regarding short-term risk, KDLYW is more volatile compared to DVA. This indicates potentially higher risk in terms of short-term price fluctuations for KDLYW.
KDLYW vs OSH Comparison
KDLYW plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, KDLYW stands at 96.5M. In comparison, OSH has a market cap of 9.5B. Regarding current trading prices, KDLYW is priced at $18.65, while OSH trades at $39.00.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
KDLYW currently has a P/E ratio of N/A, whereas OSH's P/E ratio is -17.65. In terms of profitability, KDLYW's ROE is -1.46%, compared to OSH's ROE of +4.64%. Regarding short-term risk, KDLYW is more volatile compared to OSH. This indicates potentially higher risk in terms of short-term price fluctuations for KDLYW.
KDLYW vs ENSG Comparison
KDLYW plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, KDLYW stands at 96.5M. In comparison, ENSG has a market cap of 8.9B. Regarding current trading prices, KDLYW is priced at $18.65, while ENSG trades at $154.26.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
KDLYW currently has a P/E ratio of N/A, whereas ENSG's P/E ratio is 29.11. In terms of profitability, KDLYW's ROE is -1.46%, compared to ENSG's ROE of +0.17%. Regarding short-term risk, KDLYW is more volatile compared to ENSG. This indicates potentially higher risk in terms of short-term price fluctuations for KDLYW.
KDLYW vs CHE Comparison
KDLYW plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, KDLYW stands at 96.5M. In comparison, CHE has a market cap of 7.1B. Regarding current trading prices, KDLYW is priced at $18.65, while CHE trades at $486.93.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
KDLYW currently has a P/E ratio of N/A, whereas CHE's P/E ratio is 23.75. In terms of profitability, KDLYW's ROE is -1.46%, compared to CHE's ROE of +0.26%. Regarding short-term risk, KDLYW is more volatile compared to CHE. This indicates potentially higher risk in terms of short-term price fluctuations for KDLYW.
KDLYW vs OPCH Comparison
KDLYW plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, KDLYW stands at 96.5M. In comparison, OPCH has a market cap of 5.3B. Regarding current trading prices, KDLYW is priced at $18.65, while OPCH trades at $32.48.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
KDLYW currently has a P/E ratio of N/A, whereas OPCH's P/E ratio is 25.98. In terms of profitability, KDLYW's ROE is -1.46%, compared to OPCH's ROE of +0.15%. Regarding short-term risk, KDLYW is more volatile compared to OPCH. This indicates potentially higher risk in terms of short-term price fluctuations for KDLYW.
KDLYW vs LHCG Comparison
KDLYW plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, KDLYW stands at 96.5M. In comparison, LHCG has a market cap of 5.3B. Regarding current trading prices, KDLYW is priced at $18.65, while LHCG trades at $169.81.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
KDLYW currently has a P/E ratio of N/A, whereas LHCG's P/E ratio is 82.83. In terms of profitability, KDLYW's ROE is -1.46%, compared to LHCG's ROE of +0.04%. Regarding short-term risk, KDLYW is more volatile compared to LHCG. This indicates potentially higher risk in terms of short-term price fluctuations for KDLYW.
KDLYW vs AMED Comparison
KDLYW plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, KDLYW stands at 96.5M. In comparison, AMED has a market cap of 3.2B. Regarding current trading prices, KDLYW is priced at $18.65, while AMED trades at $98.39.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
KDLYW currently has a P/E ratio of N/A, whereas AMED's P/E ratio is 36.31. In terms of profitability, KDLYW's ROE is -1.46%, compared to AMED's ROE of +0.10%. Regarding short-term risk, KDLYW is more volatile compared to AMED. This indicates potentially higher risk in terms of short-term price fluctuations for KDLYW.
KDLYW vs SGRY Comparison
KDLYW plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, KDLYW stands at 96.5M. In comparison, SGRY has a market cap of 2.8B. Regarding current trading prices, KDLYW is priced at $18.65, while SGRY trades at $22.23.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
KDLYW currently has a P/E ratio of N/A, whereas SGRY's P/E ratio is -14.53. In terms of profitability, KDLYW's ROE is -1.46%, compared to SGRY's ROE of -0.10%. Regarding short-term risk, KDLYW is more volatile compared to SGRY. This indicates potentially higher risk in terms of short-term price fluctuations for KDLYW.
KDLYW vs ADUS Comparison
KDLYW plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, KDLYW stands at 96.5M. In comparison, ADUS has a market cap of 2.1B. Regarding current trading prices, KDLYW is priced at $18.65, while ADUS trades at $115.19.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
KDLYW currently has a P/E ratio of N/A, whereas ADUS's P/E ratio is 26.06. In terms of profitability, KDLYW's ROE is -1.46%, compared to ADUS's ROE of +0.08%. Regarding short-term risk, KDLYW is more volatile compared to ADUS. This indicates potentially higher risk in terms of short-term price fluctuations for KDLYW.
KDLYW vs ACHC Comparison
KDLYW plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, KDLYW stands at 96.5M. In comparison, ACHC has a market cap of 2.1B. Regarding current trading prices, KDLYW is priced at $18.65, while ACHC trades at $22.69.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
KDLYW currently has a P/E ratio of N/A, whereas ACHC's P/E ratio is 11.12. In terms of profitability, KDLYW's ROE is -1.46%, compared to ACHC's ROE of +0.06%. Regarding short-term risk, KDLYW is more volatile compared to ACHC. This indicates potentially higher risk in terms of short-term price fluctuations for KDLYW.
KDLYW vs LFST Comparison
KDLYW plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, KDLYW stands at 96.5M. In comparison, LFST has a market cap of 2B. Regarding current trading prices, KDLYW is priced at $18.65, while LFST trades at $5.17.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
KDLYW currently has a P/E ratio of N/A, whereas LFST's P/E ratio is -57.44. In terms of profitability, KDLYW's ROE is -1.46%, compared to LFST's ROE of -0.02%. Regarding short-term risk, KDLYW is more volatile compared to LFST. This indicates potentially higher risk in terms of short-term price fluctuations for KDLYW.
KDLYW vs ARDT Comparison
KDLYW plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, KDLYW stands at 96.5M. In comparison, ARDT has a market cap of 2B. Regarding current trading prices, KDLYW is priced at $18.65, while ARDT trades at $13.66.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
KDLYW currently has a P/E ratio of N/A, whereas ARDT's P/E ratio is 8.13. In terms of profitability, KDLYW's ROE is -1.46%, compared to ARDT's ROE of +0.24%. Regarding short-term risk, KDLYW is more volatile compared to ARDT. This indicates potentially higher risk in terms of short-term price fluctuations for KDLYW.
KDLYW vs SEM Comparison
KDLYW plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, KDLYW stands at 96.5M. In comparison, SEM has a market cap of 1.9B. Regarding current trading prices, KDLYW is priced at $18.65, while SEM trades at $15.18.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
KDLYW currently has a P/E ratio of N/A, whereas SEM's P/E ratio is 24.47. In terms of profitability, KDLYW's ROE is -1.46%, compared to SEM's ROE of +0.10%. Regarding short-term risk, KDLYW is more volatile compared to SEM. This indicates potentially higher risk in terms of short-term price fluctuations for KDLYW.
KDLYW vs AMEH Comparison
KDLYW plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, KDLYW stands at 96.5M. In comparison, AMEH has a market cap of 1.8B. Regarding current trading prices, KDLYW is priced at $18.65, while AMEH trades at $40.82.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
KDLYW currently has a P/E ratio of N/A, whereas AMEH's P/E ratio is 39.25. In terms of profitability, KDLYW's ROE is -1.46%, compared to AMEH's ROE of +0.07%. Regarding short-term risk, KDLYW is more volatile compared to AMEH. This indicates potentially higher risk in terms of short-term price fluctuations for KDLYW.
KDLYW vs NHC Comparison
KDLYW plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, KDLYW stands at 96.5M. In comparison, NHC has a market cap of 1.7B. Regarding current trading prices, KDLYW is priced at $18.65, while NHC trades at $107.01.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
KDLYW currently has a P/E ratio of N/A, whereas NHC's P/E ratio is 15.44. In terms of profitability, KDLYW's ROE is -1.46%, compared to NHC's ROE of +0.11%. Regarding short-term risk, KDLYW is more volatile compared to NHC. This indicates potentially higher risk in terms of short-term price fluctuations for KDLYW.
KDLYW vs BKD Comparison
KDLYW plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, KDLYW stands at 96.5M. In comparison, BKD has a market cap of 1.6B. Regarding current trading prices, KDLYW is priced at $18.65, while BKD trades at $6.96.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
KDLYW currently has a P/E ratio of N/A, whereas BKD's P/E ratio is -6.70. In terms of profitability, KDLYW's ROE is -1.46%, compared to BKD's ROE of -0.96%. Regarding short-term risk, KDLYW is more volatile compared to BKD. This indicates potentially higher risk in terms of short-term price fluctuations for KDLYW.
KDLYW vs ASTH Comparison
KDLYW plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, KDLYW stands at 96.5M. In comparison, ASTH has a market cap of 1.2B. Regarding current trading prices, KDLYW is priced at $18.65, while ASTH trades at $24.88.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
KDLYW currently has a P/E ratio of N/A, whereas ASTH's P/E ratio is 34.08. In terms of profitability, KDLYW's ROE is -1.46%, compared to ASTH's ROE of +0.07%. Regarding short-term risk, KDLYW is more volatile compared to ASTH. This indicates potentially higher risk in terms of short-term price fluctuations for KDLYW.
KDLYW vs MD Comparison
KDLYW plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, KDLYW stands at 96.5M. In comparison, MD has a market cap of 1.2B. Regarding current trading prices, KDLYW is priced at $18.65, while MD trades at $14.35.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
KDLYW currently has a P/E ratio of N/A, whereas MD's P/E ratio is -14.37. In terms of profitability, KDLYW's ROE is -1.46%, compared to MD's ROE of -0.11%. Regarding short-term risk, KDLYW is more volatile compared to MD. This indicates potentially higher risk in terms of short-term price fluctuations for KDLYW.
KDLYW vs BKDT Comparison
KDLYW plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, KDLYW stands at 96.5M. In comparison, BKDT has a market cap of 1.2B. Regarding current trading prices, KDLYW is priced at $18.65, while BKDT trades at $77.60.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
KDLYW currently has a P/E ratio of N/A, whereas BKDT's P/E ratio is N/A. In terms of profitability, KDLYW's ROE is -1.46%, compared to BKDT's ROE of -0.96%. Regarding short-term risk, KDLYW is more volatile compared to BKDT. This indicates potentially higher risk in terms of short-term price fluctuations for KDLYW.
KDLYW vs USPH Comparison
KDLYW plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, KDLYW stands at 96.5M. In comparison, USPH has a market cap of 1.2B. Regarding current trading prices, KDLYW is priced at $18.65, while USPH trades at $78.20.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
KDLYW currently has a P/E ratio of N/A, whereas USPH's P/E ratio is 35.88. In terms of profitability, KDLYW's ROE is -1.46%, compared to USPH's ROE of +0.06%. Regarding short-term risk, KDLYW is more volatile compared to USPH. This indicates potentially higher risk in terms of short-term price fluctuations for KDLYW.
KDLYW vs HCSG Comparison
KDLYW plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, KDLYW stands at 96.5M. In comparison, HCSG has a market cap of 1.1B. Regarding current trading prices, KDLYW is priced at $18.65, while HCSG trades at $15.03.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
KDLYW currently has a P/E ratio of N/A, whereas HCSG's P/E ratio is 27.33. In terms of profitability, KDLYW's ROE is -1.46%, compared to HCSG's ROE of +0.08%. Regarding short-term risk, KDLYW is more volatile compared to HCSG. This indicates potentially higher risk in terms of short-term price fluctuations for KDLYW.
KDLYW vs PNTG Comparison
KDLYW plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, KDLYW stands at 96.5M. In comparison, PNTG has a market cap of 1B. Regarding current trading prices, KDLYW is priced at $18.65, while PNTG trades at $29.85.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
KDLYW currently has a P/E ratio of N/A, whereas PNTG's P/E ratio is 39.28. In terms of profitability, KDLYW's ROE is -1.46%, compared to PNTG's ROE of +0.11%. Regarding short-term risk, KDLYW is more volatile compared to PNTG. This indicates potentially higher risk in terms of short-term price fluctuations for KDLYW.
KDLYW vs AVAH Comparison
KDLYW plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, KDLYW stands at 96.5M. In comparison, AVAH has a market cap of 1B. Regarding current trading prices, KDLYW is priced at $18.65, while AVAH trades at $5.23.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
KDLYW currently has a P/E ratio of N/A, whereas AVAH's P/E ratio is 174.33. In terms of profitability, KDLYW's ROE is -1.46%, compared to AVAH's ROE of -0.12%. Regarding short-term risk, KDLYW is more volatile compared to AVAH. This indicates potentially higher risk in terms of short-term price fluctuations for KDLYW.
KDLYW vs AGL Comparison
KDLYW plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, KDLYW stands at 96.5M. In comparison, AGL has a market cap of 945.9M. Regarding current trading prices, KDLYW is priced at $18.65, while AGL trades at $2.30.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
KDLYW currently has a P/E ratio of N/A, whereas AGL's P/E ratio is -3.69. In terms of profitability, KDLYW's ROE is -1.46%, compared to AGL's ROE of -0.44%. Regarding short-term risk, KDLYW is more volatile compared to AGL. This indicates potentially higher risk in terms of short-term price fluctuations for KDLYW.
KDLYW vs AMN Comparison
KDLYW plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, KDLYW stands at 96.5M. In comparison, AMN has a market cap of 791.3M. Regarding current trading prices, KDLYW is priced at $18.65, while AMN trades at $20.67.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
KDLYW currently has a P/E ratio of N/A, whereas AMN's P/E ratio is -4.77. In terms of profitability, KDLYW's ROE is -1.46%, compared to AMN's ROE of -0.21%. Regarding short-term risk, KDLYW is more volatile compared to AMN. This indicates potentially higher risk in terms of short-term price fluctuations for KDLYW.
KDLYW vs INNV Comparison
KDLYW plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, KDLYW stands at 96.5M. In comparison, INNV has a market cap of 498.2M. Regarding current trading prices, KDLYW is priced at $18.65, while INNV trades at $3.69.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
KDLYW currently has a P/E ratio of N/A, whereas INNV's P/E ratio is -15.37. In terms of profitability, KDLYW's ROE is -1.46%, compared to INNV's ROE of -0.12%. Regarding short-term risk, KDLYW is more volatile compared to INNV. This indicates potentially higher risk in terms of short-term price fluctuations for KDLYW.
KDLYW vs EHAB Comparison
KDLYW plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, KDLYW stands at 96.5M. In comparison, EHAB has a market cap of 488.1M. Regarding current trading prices, KDLYW is priced at $18.65, while EHAB trades at $9.64.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
KDLYW currently has a P/E ratio of N/A, whereas EHAB's P/E ratio is -3.48. In terms of profitability, KDLYW's ROE is -1.46%, compared to EHAB's ROE of -0.31%. Regarding short-term risk, KDLYW is more volatile compared to EHAB. This indicates potentially higher risk in terms of short-term price fluctuations for KDLYW.
KDLYW vs CYH Comparison
KDLYW plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, KDLYW stands at 96.5M. In comparison, CYH has a market cap of 476.3M. Regarding current trading prices, KDLYW is priced at $18.65, while CYH trades at $3.40.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
KDLYW currently has a P/E ratio of N/A, whereas CYH's P/E ratio is -0.92. In terms of profitability, KDLYW's ROE is -1.46%, compared to CYH's ROE of +0.30%. Regarding short-term risk, KDLYW is more volatile compared to CYH. This indicates potentially higher risk in terms of short-term price fluctuations for KDLYW.
KDLYW vs SNDA Comparison
KDLYW plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, KDLYW stands at 96.5M. In comparison, SNDA has a market cap of 469.6M. Regarding current trading prices, KDLYW is priced at $18.65, while SNDA trades at $24.95.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
KDLYW currently has a P/E ratio of N/A, whereas SNDA's P/E ratio is -6.86. In terms of profitability, KDLYW's ROE is -1.46%, compared to SNDA's ROE of -0.53%. Regarding short-term risk, KDLYW is more volatile compared to SNDA. This indicates potentially higher risk in terms of short-term price fluctuations for KDLYW.
KDLYW vs TALK Comparison
KDLYW plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, KDLYW stands at 96.5M. In comparison, TALK has a market cap of 465.1M. Regarding current trading prices, KDLYW is priced at $18.65, while TALK trades at $2.78.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
KDLYW currently has a P/E ratio of N/A, whereas TALK's P/E ratio is 139.00. In terms of profitability, KDLYW's ROE is -1.46%, compared to TALK's ROE of -0.04%. Regarding short-term risk, KDLYW is more volatile compared to TALK. This indicates potentially higher risk in terms of short-term price fluctuations for KDLYW.
KDLYW vs AUNA Comparison
KDLYW plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, KDLYW stands at 96.5M. In comparison, AUNA has a market cap of 456.7M. Regarding current trading prices, KDLYW is priced at $18.65, while AUNA trades at $6.20.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
KDLYW currently has a P/E ratio of N/A, whereas AUNA's P/E ratio is 9.49. In terms of profitability, KDLYW's ROE is -1.46%, compared to AUNA's ROE of +0.07%. Regarding short-term risk, KDLYW is more volatile compared to AUNA. This indicates potentially higher risk in terms of short-term price fluctuations for KDLYW.
KDLYW vs TALKW Comparison
KDLYW plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, KDLYW stands at 96.5M. In comparison, TALKW has a market cap of 454.1M. Regarding current trading prices, KDLYW is priced at $18.65, while TALKW trades at $0.07.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
KDLYW currently has a P/E ratio of N/A, whereas TALKW's P/E ratio is N/A. In terms of profitability, KDLYW's ROE is -1.46%, compared to TALKW's ROE of -0.04%. Regarding short-term risk, KDLYW is more volatile compared to TALKW. This indicates potentially higher risk in terms of short-term price fluctuations for KDLYW.
KDLYW vs CCRN Comparison
KDLYW plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, KDLYW stands at 96.5M. In comparison, CCRN has a market cap of 427.8M. Regarding current trading prices, KDLYW is priced at $18.65, while CCRN trades at $13.05.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
KDLYW currently has a P/E ratio of N/A, whereas CCRN's P/E ratio is -24.17. In terms of profitability, KDLYW's ROE is -1.46%, compared to CCRN's ROE of -0.04%. Regarding short-term risk, KDLYW is more volatile compared to CCRN. This indicates potentially higher risk in terms of short-term price fluctuations for KDLYW.
KDLYW vs AONC Comparison
KDLYW plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, KDLYW stands at 96.5M. In comparison, AONC has a market cap of 408.3M. Regarding current trading prices, KDLYW is priced at $18.65, while AONC trades at $14.00.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
KDLYW currently has a P/E ratio of N/A, whereas AONC's P/E ratio is -15.73. In terms of profitability, KDLYW's ROE is -1.46%, compared to AONC's ROE of +0.25%. Regarding short-term risk, KDLYW is more volatile compared to AONC. This indicates potentially higher risk in terms of short-term price fluctuations for KDLYW.
KDLYW vs AIRS Comparison
KDLYW plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, KDLYW stands at 96.5M. In comparison, AIRS has a market cap of 301.5M. Regarding current trading prices, KDLYW is priced at $18.65, while AIRS trades at $4.83.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
KDLYW currently has a P/E ratio of N/A, whereas AIRS's P/E ratio is -16.66. In terms of profitability, KDLYW's ROE is -1.46%, compared to AIRS's ROE of -0.21%. Regarding short-term risk, KDLYW is more volatile compared to AIRS. This indicates potentially higher risk in terms of short-term price fluctuations for KDLYW.
KDLYW vs CMPS Comparison
KDLYW plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, KDLYW stands at 96.5M. In comparison, CMPS has a market cap of 260M. Regarding current trading prices, KDLYW is priced at $18.65, while CMPS trades at $2.80.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
KDLYW currently has a P/E ratio of N/A, whereas CMPS's P/E ratio is -1.41. In terms of profitability, KDLYW's ROE is -1.46%, compared to CMPS's ROE of -0.72%. Regarding short-term risk, KDLYW is more volatile compared to CMPS. This indicates potentially higher risk in terms of short-term price fluctuations for KDLYW.
KDLYW vs CSU Comparison
KDLYW plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, KDLYW stands at 96.5M. In comparison, CSU has a market cap of 223.7M. Regarding current trading prices, KDLYW is priced at $18.65, while CSU trades at $33.54.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
KDLYW currently has a P/E ratio of N/A, whereas CSU's P/E ratio is 0.67. In terms of profitability, KDLYW's ROE is -1.46%, compared to CSU's ROE of +2.23%. Regarding short-term risk, KDLYW is more volatile compared to CSU. This indicates potentially higher risk in terms of short-term price fluctuations for KDLYW.
KDLYW vs TOIIW Comparison
KDLYW plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, KDLYW stands at 96.5M. In comparison, TOIIW has a market cap of 208.7M. Regarding current trading prices, KDLYW is priced at $18.65, while TOIIW trades at $0.05.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
KDLYW currently has a P/E ratio of N/A, whereas TOIIW's P/E ratio is N/A. In terms of profitability, KDLYW's ROE is -1.46%, compared to TOIIW's ROE of -4.83%. Regarding short-term risk, KDLYW is more volatile compared to TOIIW. This indicates potentially higher risk in terms of short-term price fluctuations for KDLYW.
KDLYW vs TOI Comparison
KDLYW plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, KDLYW stands at 96.5M. In comparison, TOI has a market cap of 188.4M. Regarding current trading prices, KDLYW is priced at $18.65, while TOI trades at $2.05.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
KDLYW currently has a P/E ratio of N/A, whereas TOI's P/E ratio is -2.93. In terms of profitability, KDLYW's ROE is -1.46%, compared to TOI's ROE of -4.83%. Regarding short-term risk, KDLYW is more volatile compared to TOI. This indicates potentially higher risk in terms of short-term price fluctuations for KDLYW.
KDLYW vs JYNT Comparison
KDLYW plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, KDLYW stands at 96.5M. In comparison, JYNT has a market cap of 176.6M. Regarding current trading prices, KDLYW is priced at $18.65, while JYNT trades at $11.54.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
KDLYW currently has a P/E ratio of N/A, whereas JYNT's P/E ratio is -115.40. In terms of profitability, KDLYW's ROE is -1.46%, compared to JYNT's ROE of -0.43%. Regarding short-term risk, KDLYW is more volatile compared to JYNT. This indicates potentially higher risk in terms of short-term price fluctuations for KDLYW.
KDLYW vs DCGO Comparison
KDLYW plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, KDLYW stands at 96.5M. In comparison, DCGO has a market cap of 155.6M. Regarding current trading prices, KDLYW is priced at $18.65, while DCGO trades at $1.57.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
KDLYW currently has a P/E ratio of N/A, whereas DCGO's P/E ratio is -157.00. In terms of profitability, KDLYW's ROE is -1.46%, compared to DCGO's ROE of -0.00%. Regarding short-term risk, KDLYW is more volatile compared to DCGO. This indicates potentially higher risk in terms of short-term price fluctuations for KDLYW.
KDLYW vs BTMD Comparison
KDLYW plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, KDLYW stands at 96.5M. In comparison, BTMD has a market cap of 153.9M. Regarding current trading prices, KDLYW is priced at $18.65, while BTMD trades at $4.02.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
KDLYW currently has a P/E ratio of N/A, whereas BTMD's P/E ratio is 6.93. In terms of profitability, KDLYW's ROE is -1.46%, compared to BTMD's ROE of -0.19%. Regarding short-term risk, KDLYW is more volatile compared to BTMD. This indicates potentially higher risk in terms of short-term price fluctuations for KDLYW.
KDLYW vs FVE Comparison
KDLYW plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, KDLYW stands at 96.5M. In comparison, FVE has a market cap of 98.4M. Regarding current trading prices, KDLYW is priced at $18.65, while FVE trades at $2.94.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
KDLYW currently has a P/E ratio of N/A, whereas FVE's P/E ratio is -5.64. In terms of profitability, KDLYW's ROE is -1.46%, compared to FVE's ROE of -0.15%. Regarding short-term risk, KDLYW is more volatile compared to FVE. This indicates potentially higher risk in terms of short-term price fluctuations for KDLYW.
KDLYW vs MODV Comparison
KDLYW plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, KDLYW stands at 96.5M. In comparison, MODV has a market cap of 44.8M. Regarding current trading prices, KDLYW is priced at $18.65, while MODV trades at $3.12.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
KDLYW currently has a P/E ratio of N/A, whereas MODV's P/E ratio is -0.19. In terms of profitability, KDLYW's ROE is -1.46%, compared to MODV's ROE of +6.87%. Regarding short-term risk, KDLYW is more volatile compared to MODV. This indicates potentially higher risk in terms of short-term price fluctuations for KDLYW.
KDLYW vs ALR Comparison
KDLYW plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, KDLYW stands at 96.5M. In comparison, ALR has a market cap of 44.2M. Regarding current trading prices, KDLYW is priced at $18.65, while ALR trades at $1.32.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
KDLYW currently has a P/E ratio of N/A, whereas ALR's P/E ratio is -1.11. In terms of profitability, KDLYW's ROE is -1.46%, compared to ALR's ROE of -0.15%. Regarding short-term risk, KDLYW is more volatile compared to ALR. This indicates potentially higher risk in terms of short-term price fluctuations for KDLYW.
KDLYW vs CCEL Comparison
KDLYW plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, KDLYW stands at 96.5M. In comparison, CCEL has a market cap of 42M. Regarding current trading prices, KDLYW is priced at $18.65, while CCEL trades at $5.19.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
KDLYW currently has a P/E ratio of N/A, whereas CCEL's P/E ratio is 519.50. In terms of profitability, KDLYW's ROE is -1.46%, compared to CCEL's ROE of -0.01%. Regarding short-term risk, KDLYW is more volatile compared to CCEL. This indicates potentially higher risk in terms of short-term price fluctuations for KDLYW.
KDLYW vs IMAC Comparison
KDLYW plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, KDLYW stands at 96.5M. In comparison, IMAC has a market cap of 33.1M. Regarding current trading prices, KDLYW is priced at $18.65, while IMAC trades at $1.01.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
KDLYW currently has a P/E ratio of N/A, whereas IMAC's P/E ratio is -2.27. In terms of profitability, KDLYW's ROE is -1.46%, compared to IMAC's ROE of +2.46%. Regarding short-term risk, KDLYW is more volatile compared to IMAC. This indicates potentially higher risk in terms of short-term price fluctuations for KDLYW.
KDLYW vs PIII Comparison
KDLYW plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, KDLYW stands at 96.5M. In comparison, PIII has a market cap of 20.6M. Regarding current trading prices, KDLYW is priced at $18.65, while PIII trades at $6.30.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
KDLYW currently has a P/E ratio of N/A, whereas PIII's P/E ratio is -0.12. In terms of profitability, KDLYW's ROE is -1.46%, compared to PIII's ROE of -1.29%. Regarding short-term risk, KDLYW is more volatile compared to PIII. This indicates potentially higher risk in terms of short-term price fluctuations for KDLYW.
KDLYW vs AIH Comparison
KDLYW plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, KDLYW stands at 96.5M. In comparison, AIH has a market cap of 15.9M. Regarding current trading prices, KDLYW is priced at $18.65, while AIH trades at $0.33.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
KDLYW currently has a P/E ratio of N/A, whereas AIH's P/E ratio is -2.78. In terms of profitability, KDLYW's ROE is -1.46%, compared to AIH's ROE of +1.16%. Regarding short-term risk, KDLYW is more volatile compared to AIH. This indicates potentially higher risk in terms of short-term price fluctuations for KDLYW.
KDLYW vs AMS Comparison
KDLYW plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, KDLYW stands at 96.5M. In comparison, AMS has a market cap of 15.5M. Regarding current trading prices, KDLYW is priced at $18.65, while AMS trades at $2.41.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
KDLYW currently has a P/E ratio of N/A, whereas AMS's P/E ratio is 11.43. In terms of profitability, KDLYW's ROE is -1.46%, compared to AMS's ROE of +0.06%. Regarding short-term risk, KDLYW is more volatile compared to AMS. This indicates potentially higher risk in terms of short-term price fluctuations for KDLYW.
KDLYW vs CANO Comparison
KDLYW plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, KDLYW stands at 96.5M. In comparison, CANO has a market cap of 12.4M. Regarding current trading prices, KDLYW is priced at $18.65, while CANO trades at $2.30.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
KDLYW currently has a P/E ratio of N/A, whereas CANO's P/E ratio is -0.01. In terms of profitability, KDLYW's ROE is -1.46%, compared to CANO's ROE of -1.49%. Regarding short-term risk, KDLYW is more volatile compared to CANO. This indicates potentially higher risk in terms of short-term price fluctuations for KDLYW.
KDLYW vs FTRP Comparison
KDLYW plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, KDLYW stands at 96.5M. In comparison, FTRP has a market cap of 9.8M. Regarding current trading prices, KDLYW is priced at $18.65, while FTRP trades at $0.84.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
KDLYW currently has a P/E ratio of N/A, whereas FTRP's P/E ratio is -1.22. In terms of profitability, KDLYW's ROE is -1.46%, compared to FTRP's ROE of -0.62%. Regarding short-term risk, KDLYW is more volatile compared to FTRP. This indicates potentially higher risk in terms of short-term price fluctuations for KDLYW.
KDLYW vs GBNH Comparison
KDLYW plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, KDLYW stands at 96.5M. In comparison, GBNH has a market cap of 5.5M. Regarding current trading prices, KDLYW is priced at $18.65, while GBNH trades at $0.12.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
KDLYW currently has a P/E ratio of N/A, whereas GBNH's P/E ratio is -0.06. In terms of profitability, KDLYW's ROE is -1.46%, compared to GBNH's ROE of +15.74%. Regarding short-term risk, KDLYW is less volatile compared to GBNH. This indicates potentially lower risk in terms of short-term price fluctuations for KDLYW.
KDLYW vs RHE Comparison
KDLYW plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, KDLYW stands at 96.5M. In comparison, RHE has a market cap of 5.2M. Regarding current trading prices, KDLYW is priced at $18.65, while RHE trades at $2.77.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
KDLYW currently has a P/E ratio of N/A, whereas RHE's P/E ratio is -1.79. In terms of profitability, KDLYW's ROE is -1.46%, compared to RHE's ROE of +1.52%. Regarding short-term risk, KDLYW is more volatile compared to RHE. This indicates potentially higher risk in terms of short-term price fluctuations for KDLYW.
KDLYW vs NIVFW Comparison
KDLYW plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, KDLYW stands at 96.5M. In comparison, NIVFW has a market cap of 5.1M. Regarding current trading prices, KDLYW is priced at $18.65, while NIVFW trades at $0.03.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
KDLYW currently has a P/E ratio of N/A, whereas NIVFW's P/E ratio is N/A. In terms of profitability, KDLYW's ROE is -1.46%, compared to NIVFW's ROE of -0.39%. Regarding short-term risk, KDLYW is more volatile compared to NIVFW. This indicates potentially higher risk in terms of short-term price fluctuations for KDLYW.
KDLYW vs MNDR Comparison
KDLYW plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, KDLYW stands at 96.5M. In comparison, MNDR has a market cap of 4.7M. Regarding current trading prices, KDLYW is priced at $18.65, while MNDR trades at $1.07.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
KDLYW currently has a P/E ratio of N/A, whereas MNDR's P/E ratio is -0.15. In terms of profitability, KDLYW's ROE is -1.46%, compared to MNDR's ROE of -5.70%. Regarding short-term risk, KDLYW is more volatile compared to MNDR. This indicates potentially higher risk in terms of short-term price fluctuations for KDLYW.
KDLYW vs ATIP Comparison
KDLYW plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, KDLYW stands at 96.5M. In comparison, ATIP has a market cap of 3.8M. Regarding current trading prices, KDLYW is priced at $18.65, while ATIP trades at $0.86.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
KDLYW currently has a P/E ratio of N/A, whereas ATIP's P/E ratio is -0.04. In terms of profitability, KDLYW's ROE is -1.46%, compared to ATIP's ROE of +1.77%. Regarding short-term risk, KDLYW is more volatile compared to ATIP. This indicates potentially higher risk in terms of short-term price fluctuations for KDLYW.
KDLYW vs IMACW Comparison
KDLYW plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, KDLYW stands at 96.5M. In comparison, IMACW has a market cap of 1.7M. Regarding current trading prices, KDLYW is priced at $18.65, while IMACW trades at $0.01.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
KDLYW currently has a P/E ratio of N/A, whereas IMACW's P/E ratio is N/A. In terms of profitability, KDLYW's ROE is -1.46%, compared to IMACW's ROE of +2.46%. Regarding short-term risk, KDLYW is less volatile compared to IMACW. This indicates potentially lower risk in terms of short-term price fluctuations for KDLYW.
KDLYW vs SYRA Comparison
KDLYW plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, KDLYW stands at 96.5M. In comparison, SYRA has a market cap of 1.1M. Regarding current trading prices, KDLYW is priced at $18.65, while SYRA trades at $0.11.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
KDLYW currently has a P/E ratio of N/A, whereas SYRA's P/E ratio is -0.28. In terms of profitability, KDLYW's ROE is -1.46%, compared to SYRA's ROE of -1.04%. Regarding short-term risk, KDLYW is more volatile compared to SYRA. This indicates potentially higher risk in terms of short-term price fluctuations for KDLYW.
KDLYW vs CCM Comparison
KDLYW plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, KDLYW stands at 96.5M. In comparison, CCM has a market cap of 840K. Regarding current trading prices, KDLYW is priced at $18.65, while CCM trades at $5.73.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
KDLYW currently has a P/E ratio of N/A, whereas CCM's P/E ratio is -0.58. In terms of profitability, KDLYW's ROE is -1.46%, compared to CCM's ROE of +0.13%. Regarding short-term risk, KDLYW is more volatile compared to CCM. This indicates potentially higher risk in terms of short-term price fluctuations for KDLYW.
KDLYW vs RHE-PA Comparison
KDLYW plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, KDLYW stands at 96.5M. In comparison, RHE-PA has a market cap of 674.5K. Regarding current trading prices, KDLYW is priced at $18.65, while RHE-PA trades at $0.68.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
KDLYW currently has a P/E ratio of N/A, whereas RHE-PA's P/E ratio is -0.09. In terms of profitability, KDLYW's ROE is -1.46%, compared to RHE-PA's ROE of +1.52%. Regarding short-term risk, KDLYW is more volatile compared to RHE-PA. This indicates potentially higher risk in terms of short-term price fluctuations for KDLYW.
KDLYW vs BACK Comparison
KDLYW plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, KDLYW stands at 96.5M. In comparison, BACK has a market cap of 189.2K. Regarding current trading prices, KDLYW is priced at $18.65, while BACK trades at $0.05.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
KDLYW currently has a P/E ratio of N/A, whereas BACK's P/E ratio is -0.01. In terms of profitability, KDLYW's ROE is -1.46%, compared to BACK's ROE of +2.46%. Regarding short-term risk, KDLYW is more volatile compared to BACK. This indicates potentially higher risk in terms of short-term price fluctuations for KDLYW.
KDLYW vs IONM Comparison
KDLYW plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, KDLYW stands at 96.5M. In comparison, IONM has a market cap of 149.8K. Regarding current trading prices, KDLYW is priced at $18.65, while IONM trades at $0.05.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
KDLYW currently has a P/E ratio of N/A, whereas IONM's P/E ratio is N/A. In terms of profitability, KDLYW's ROE is -1.46%, compared to IONM's ROE of +0.75%. Regarding short-term risk, KDLYW is less volatile compared to IONM. This indicates potentially lower risk in terms of short-term price fluctuations for KDLYW.
KDLYW vs PIIIW Comparison
KDLYW plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, KDLYW stands at 96.5M. In comparison, PIIIW has a market cap of 36.6K. Regarding current trading prices, KDLYW is priced at $18.65, while PIIIW trades at $0.01.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
KDLYW currently has a P/E ratio of N/A, whereas PIIIW's P/E ratio is -0.01. In terms of profitability, KDLYW's ROE is -1.46%, compared to PIIIW's ROE of -1.29%. Regarding short-term risk, KDLYW is more volatile compared to PIIIW. This indicates potentially higher risk in terms of short-term price fluctuations for KDLYW.
KDLYW vs NVOS Comparison
KDLYW plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, KDLYW stands at 96.5M. In comparison, NVOS has a market cap of 7.9K. Regarding current trading prices, KDLYW is priced at $18.65, while NVOS trades at $0.00.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
KDLYW currently has a P/E ratio of N/A, whereas NVOS's P/E ratio is N/A. In terms of profitability, KDLYW's ROE is -1.46%, compared to NVOS's ROE of -1.20%. Regarding short-term risk, KDLYW is more volatile compared to NVOS. This indicates potentially higher risk in terms of short-term price fluctuations for KDLYW.
KDLYW vs SLHGP Comparison
KDLYW plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, KDLYW stands at 96.5M. In comparison, SLHGP has a market cap of 0. Regarding current trading prices, KDLYW is priced at $18.65, while SLHGP trades at $12.00.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
KDLYW currently has a P/E ratio of N/A, whereas SLHGP's P/E ratio is -30.38. In terms of profitability, KDLYW's ROE is -1.46%, compared to SLHGP's ROE of -0.71%. Regarding short-term risk, KDLYW is more volatile compared to SLHGP. This indicates potentially higher risk in terms of short-term price fluctuations for KDLYW.
KDLYW vs TVTY Comparison
KDLYW plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, KDLYW stands at 96.5M. In comparison, TVTY has a market cap of 0. Regarding current trading prices, KDLYW is priced at $18.65, while TVTY trades at $32.50.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
KDLYW currently has a P/E ratio of N/A, whereas TVTY's P/E ratio is 19.06. In terms of profitability, KDLYW's ROE is -1.46%, compared to TVTY's ROE of +1.75%. Regarding short-term risk, KDLYW is more volatile compared to TVTY. This indicates potentially higher risk in terms of short-term price fluctuations for KDLYW.
KDLYW vs SLHG Comparison
KDLYW plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, KDLYW stands at 96.5M. In comparison, SLHG has a market cap of 0. Regarding current trading prices, KDLYW is priced at $18.65, while SLHG trades at $0.58.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
KDLYW currently has a P/E ratio of N/A, whereas SLHG's P/E ratio is -1.48. In terms of profitability, KDLYW's ROE is -1.46%, compared to SLHG's ROE of N/A. Regarding short-term risk, KDLYW is more volatile compared to SLHG. This indicates potentially higher risk in terms of short-term price fluctuations for KDLYW.
KDLYW vs DVCR Comparison
KDLYW plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, KDLYW stands at 96.5M. In comparison, DVCR has a market cap of 0. Regarding current trading prices, KDLYW is priced at $18.65, while DVCR trades at $10.09.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
KDLYW currently has a P/E ratio of N/A, whereas DVCR's P/E ratio is 28.34. In terms of profitability, KDLYW's ROE is -1.46%, compared to DVCR's ROE of -0.15%. Regarding short-term risk, KDLYW is more volatile compared to DVCR. This indicates potentially higher risk in terms of short-term price fluctuations for KDLYW.
KDLYW vs NFH Comparison
KDLYW plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, KDLYW stands at 96.5M. In comparison, NFH has a market cap of 0. Regarding current trading prices, KDLYW is priced at $18.65, while NFH trades at $11.95.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
KDLYW currently has a P/E ratio of N/A, whereas NFH's P/E ratio is -19.75. In terms of profitability, KDLYW's ROE is -1.46%, compared to NFH's ROE of -0.06%. Regarding short-term risk, KDLYW is more volatile compared to NFH. This indicates potentially higher risk in terms of short-term price fluctuations for KDLYW.
KDLYW vs TLMDW Comparison
KDLYW plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, KDLYW stands at 96.5M. In comparison, TLMDW has a market cap of 0. Regarding current trading prices, KDLYW is priced at $18.65, while TLMDW trades at $0.84.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
KDLYW currently has a P/E ratio of N/A, whereas TLMDW's P/E ratio is N/A. In terms of profitability, KDLYW's ROE is -1.46%, compared to TLMDW's ROE of -0.46%. Regarding short-term risk, KDLYW is more volatile compared to TLMDW. This indicates potentially higher risk in terms of short-term price fluctuations for KDLYW.
KDLYW vs TLMD Comparison
KDLYW plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, KDLYW stands at 96.5M. In comparison, TLMD has a market cap of 0. Regarding current trading prices, KDLYW is priced at $18.65, while TLMD trades at $3.00.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
KDLYW currently has a P/E ratio of N/A, whereas TLMD's P/E ratio is -1.60. In terms of profitability, KDLYW's ROE is -1.46%, compared to TLMD's ROE of -0.46%. Regarding short-term risk, KDLYW is more volatile compared to TLMD. This indicates potentially higher risk in terms of short-term price fluctuations for KDLYW.
KDLYW vs HNGR Comparison
KDLYW plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, KDLYW stands at 96.5M. In comparison, HNGR has a market cap of 0. Regarding current trading prices, KDLYW is priced at $18.65, while HNGR trades at $18.72.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
KDLYW currently has a P/E ratio of N/A, whereas HNGR's P/E ratio is 19.71. In terms of profitability, KDLYW's ROE is -1.46%, compared to HNGR's ROE of +0.52%. Regarding short-term risk, KDLYW is more volatile compared to HNGR. This indicates potentially higher risk in terms of short-term price fluctuations for KDLYW.
KDLYW vs DCGOW Comparison
KDLYW plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, KDLYW stands at 96.5M. In comparison, DCGOW has a market cap of 0. Regarding current trading prices, KDLYW is priced at $18.65, while DCGOW trades at $1.96.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
KDLYW currently has a P/E ratio of N/A, whereas DCGOW's P/E ratio is N/A. In terms of profitability, KDLYW's ROE is -1.46%, compared to DCGOW's ROE of -0.00%. Regarding short-term risk, KDLYW is more volatile compared to DCGOW. This indicates potentially higher risk in terms of short-term price fluctuations for KDLYW.